MSB 5.24% $1.11 mesoblast limited

Previous announcements have indicated that if the trial results...

  1. 349 Posts.
    lightbulb Created with Sketch. 7
    Previous announcements have indicated that if the trial results are showing overwhelming efficacy the treatment will be granted approval as per FDA guide lines.
    So at 45% with the expected announcement early November there is a chance the trial could be granted approval by the FDA.
    Alot of people will be able to recover instead of dying or being on a MECHANICAL VENTALATOR for an extended period which has lasting consequences.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.11
Change
0.055(5.24%)
Mkt cap ! $1.261B
Open High Low Value Volume
$1.05 $1.13 $1.04 $6.781M 6.207M

Buyers (Bids)

No. Vol. Price($)
3 43856 $1.11
 

Sellers (Offers)

Price($) Vol. No.
$1.11 66000 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.